On January 2, the State Food and Drug Administration conditionally approved the marketing of my country's first stem cell treatment drug, Amimetosa Injection, through the priority review and approval process.

In 2024, nearly 35 domestic iPSC companies entered the market, promoting the rapid progress of universal cell therapies.

In the vast field of medical research, human amniotic mesenchymal stem cells (hAMSC) are gradually coming into prominence.

Human body: A living body composed of approximately 40 trillion cells

A total of 23 military hospitals have been approved as stem cell clinical research filing institutions!

2024 China Stem Cell Industry Market Research Report

Among the encouraged categories, cell culture, cell therapy drugs, and high-end intelligent pharmaceutical equipment are included in the list of encouraged industries.

iPSC-MSC is the product with the most potential to replace adult MSC.